2012-11-23 13:28:28 - Narcolepsy Therapeutics - A Global Business Report - a new market research report on companiesandmarkets.com
The global market for Narcolepsy Therapeutics is projected to exceed US$395 million by the year 2015. Though a relatively small market, the global narcolepsy market exhibited significant growth since 2003, driven by an increase in awareness about the disorder and substantial market penetration of two key drugs used in the treatment of narcolepsy - Provigil (Modafinil) and Xyrem (Sodium oxybate). Patent expiry of Provigil in 2012 and black box warning for Xyrem provide significant room for other novel therapeutics, especially those with enhanced safety and efficacy.
Sleep disorders affect millions of people worldwide. The overall prevalence of sleep disorders is very high, with about 70 million people suffering from some kind of this disorder in the US alone. A high level
of significant unmet needs exist in the sleep disorders market, presenting substantial opportunities for pharma players. Narcolepsy, also known as dyssomnia, is a chronic neurological sleep disorder, caused due to the brain´s inability to regulate normal sleep-wake cycles. The disorder affects around 3 million people worldwide, and around 200,000 in the US. Two major symptoms of narcolepsy include Cataplexy and excessive daytime sleepiness.
The global market for Narcolepsy Therapeutics is dominated by two key FDA approved drugs, Provigil and Xyrem, as stated by the new market research report on Narcolepsy Therapeutics. Provigil continues to be the most widely prescribed option in the treatment of narcolepsy. Although a market leader, Provigil faces challenges of patent expiry in 2012; and competition from Xyrem. Nuvigil (Armodafinil) from Cephalon is the single isomer formulation of Provigil, developed with an aim to retain the company´s leadership in narcolepsy therapeutics market, following the patent expiry of its leading narcolepsy drug Provigil.
The report titled Narcolepsy Therapeutics: A Global Market Report provides a comprehensive review of the global narcolepsy market, the leading marketed drugs for narcolepsy, patent expiries, market trends, growth drivers, drug approvals and other regulatory filings, patent infringement lawsuits, recent corporate initiatives, and focus on select market participants. The study analyzes market data and analytics in terms of value sales for the global market. Key players profiled in the report include Addrenex Pharmaceuticals, Arena Pharmaceuticals Inc., Cephalon Inc., Evotec AG, Hypnion Inc., and Jazz Pharmaceuticals Inc.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.